Clinical Trials for Mesothelioma Patients—A Study of Azacitidine in combination with Temo/Azac: Contact Information
Read about the contact information for a current clinical trial about the use of a Phase I dose study of Azacitidine in combination with Temo/Azac for patients with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.
Contacts and Locations
Contact: Lilian Batista, BS
212-305-6837
lb2327@columbia.edu
Columbia University Medical Center
New York, New York, United States, 10032
Principal Investigator: Robert N Taub, MD
Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health
If you or a loved one has been diagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.

Inclusion criteria for clinical trial of Temo-Azac for mesothelioma